Japan Lifeline Gestione

Gestione criteri di controllo 2/4

Japan Lifeline Il CEO è Keisuke Suzuki, nominato in Jun2005, ha un mandato di 19.42 anni. possiede direttamente 15.96% delle azioni della società, per un valore di ¥ 14.25B. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 6.9 anni e 7.4 anni.

Informazioni chiave

Keisuke Suzuki

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	19.4yrs
Proprietà del CEO	16.0%
Durata media del management	6.9yrs
Durata media del Consiglio di amministrazione	7.4yrs

Aggiornamenti recenti sulla gestione

Recent updates

Analysts Have Made A Financial Statement On Japan Lifeline Co., Ltd.'s (TSE:7575) First-Quarter Report

Aug 04

Japan Lifeline Co., Ltd. Just Missed EPS By 6.2%: Here's What Analysts Think Will Happen Next

May 06

Japan Lifeline (TSE:7575) Is Increasing Its Dividend To ¥42.00

Mar 02

AMMINISTRATORE DELEGATO

Keisuke Suzuki (71 yo)

19.4yrs

Mandato

Mr. Keisuke Suzuki has been the President of Japan Lifeline Co., Ltd. since June 2005 and serves as its Chief Executive Officer since June 2005. Mr. Suzuki served as Vice President of Japan Lifeline Co., L...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Keisuke Suzuki	President	19.4yrs	Nessun dato	15.96% ¥ 14.3b
Atsuhiro Suzuki	Senior EVP	9.4yrs	Nessun dato	0.51% ¥ 456.1m
Kenji Yamada	Senior VP	no data	Nessun dato	0.039% ¥ 34.4m
Toru Takamiya	VP, Executive Manager of R&D and Manufacturing Headquarters & Director	7.4yrs	Nessun dato	0.0057% ¥ 5.1m
Tadashi Idei	VP, Executive Manager of Regulatory Affairs Headquarters & Director	7.4yrs	Nessun dato	0.0071% ¥ 6.4m
Yumiko Hoshiba	VP and Senior Manager of General Affairs Department & Director	6.4yrs	Nessun dato	0.024% ¥ 21.7m
Tatsuya Murase	SVP, Executive Manager of General Business Headquarters & Director	4.3yrs	Nessun dato	0.0071% ¥ 6.4m
Takeyoshi Egawa	VP, Senior Manager of Business Administration Dept.	1.4yrs	Nessun dato	0.0029% ¥ 2.5m
Takashi Ito	VP, Executive Manager of Arrhythmia Business Unit & Director	less than a year	Nessun dato	Nessun dato
KuNobuo Takahashi	Gen Mgr of Overseas Bus Prom Div	less than a year	Nessun dato	Nessun dato
Fumihiro Sasaki	Independent Outside Director	no data	Nessun dato	0.0057% ¥ 5.1m
Yoshiaki Ikei	Independent Outside Director	7.4yrs	Nessun dato	0.0057% ¥ 5.1m

6.9yrs

Durata media

60yo

Età media

Gestione esperta: Il team dirigenziale di 7575 è esperto e expertise (durata media dell'incarico 6.9 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Keisuke Suzuki	President	19.4yrs	Nessun dato	15.96% ¥ 14.3b
Atsuhiro Suzuki	Senior EVP	9.4yrs	Nessun dato	0.51% ¥ 456.1m
Kenji Yamada	Senior VP	no data	Nessun dato	0.039% ¥ 34.4m
Toru Takamiya	VP, Executive Manager of R&D and Manufacturing Headquarters & Director	7.4yrs	Nessun dato	0.0057% ¥ 5.1m
Tadashi Idei	VP, Executive Manager of Regulatory Affairs Headquarters & Director	7.4yrs	Nessun dato	0.0071% ¥ 6.4m
Yumiko Hoshiba	VP and Senior Manager of General Affairs Department & Director	6.4yrs	Nessun dato	0.024% ¥ 21.7m
Tatsuya Murase	SVP, Executive Manager of General Business Headquarters & Director	2.4yrs	Nessun dato	0.0071% ¥ 6.4m
Takeyoshi Egawa	VP, Senior Manager of Business Administration Dept.	1.4yrs	Nessun dato	0.0029% ¥ 2.5m
Takashi Ito	VP, Executive Manager of Arrhythmia Business Unit & Director	less than a year	Nessun dato	Nessun dato
Fumihiro Sasaki	Independent Outside Director	12.4yrs	Nessun dato	0.0057% ¥ 5.1m
Yoshiaki Ikei	Independent Outside Director	7.4yrs	Nessun dato	0.0057% ¥ 5.1m
Yutaka Karigome	Independent Outside Director	3.4yrs	Nessun dato	Nessun dato

7.4yrs

Durata media

60.5yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 7575 sono considerati esperti (durata media dell'incarico 7.4 anni).

Japan Lifeline Gestione

Gestione criteri di controllo 2/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Japan Lifeline Co., Ltd., Annual General Meeting, Jun 26, 2024

Japan Lifeline Co., Ltd. Announces the Appointment of Nobuo Takahashi as Operating Officer, Associate Executive Manager of CVG Business Unit

Japan Lifeline Co., Ltd. Announces Management Changes

Japan Lifeline Co., Ltd., Annual General Meeting, Jun 28, 2023

Japan Lifeline Announces Changes in Board of Directors, Effective June 28, 2023

Japan Lifeline Co., Ltd. Announces Executive Changes, Effective October 1, 2022 Respectively

Recent updates

Japan Lifeline Co., Ltd. to Report Q2, 2025 Results on Oct 31, 2024

Analysts Have Made A Financial Statement On Japan Lifeline Co., Ltd.'s (TSE:7575) First-Quarter Report

New major risk - Revenue and earnings growth

First quarter 2025 earnings released: EPS: JP¥31.94 (vs JP¥30.03 in 1Q 2024)

Full year 2024 earnings: EPS misses analyst expectations

Japan Lifeline Co., Ltd. to Report Q1, 2025 Results on Jul 31, 2024

Japan Lifeline Co., Ltd. Proposes Dividend for the Fiscal Year Ended March 31, 2024

Japan Lifeline Co., Ltd. Just Missed EPS By 6.2%: Here's What Analysts Think Will Happen Next

Full year 2024 earnings: EPS misses analyst expectations

Japan Lifeline Co., Ltd., Annual General Meeting, Jun 26, 2024

Upcoming dividend of JP¥42.00 per share

Japan Lifeline (TSE:7575) Is Increasing Its Dividend To ¥42.00

Japan Lifeline Co., Ltd. to Report Q4, 2024 Results on May 01, 2024

Price target increased by 11% to JP¥1,400

Third quarter 2024 earnings released: EPS: JP¥28.32 (vs JP¥11.15 in 3Q 2023)

Japan Lifeline Co., Ltd. Provides Dividend Guidance for the Year Ending March 31, 2024

Japan Lifeline Co., Ltd. Announces the Appointment of Nobuo Takahashi as Operating Officer, Associate Executive Manager of CVG Business Unit

Price target increased by 11% to JP¥1,258

New major risk - Revenue and earnings growth

Japan Lifeline Co., Ltd. Announces Management Changes

Japan Lifeline Co., Ltd. to Report Q3, 2024 Results on Feb 02, 2024

Second quarter 2024 earnings released: EPS: JP¥22.31 (vs JP¥22.54 in 2Q 2023)

Price target increased by 13% to JP¥1,280

Now 23% undervalued

Now 21% undervalued

Japan Lifeline Co., Ltd. Announces That It Will Start Selling A New Lineup of Its Proprietary Open Stent Graft Product Frozenix Partial ET from August 2023

Now 23% undervalued

First quarter 2024 earnings released: EPS: JP¥30.02 (vs JP¥24.73 in 1Q 2023)

Japan Lifeline Co., Ltd. to Report Q2, 2024 Results on Nov 06, 2023

Full year 2023 earnings: EPS misses analyst expectations

Japan Lifeline Co., Ltd., Annual General Meeting, Jun 28, 2023

Japan Lifeline Announces Changes in Board of Directors, Effective June 28, 2023

Upcoming dividend of JP¥38.00 per share at 4.1% yield

Japan Lifeline Co., Ltd. Revises Financial Forecast of Consolidated Financial Results for the Year Ending March 31, 2023

Third quarter 2023 earnings released: EPS: JP¥11.15 (vs JP¥24.01 in 3Q 2022)

Now 21% undervalued after recent price drop

Second quarter 2023 earnings released: EPS: JP¥23.64 (vs JP¥23.49 in 2Q 2022)

Second quarter 2023 earnings released: EPS: JP¥23.64 (vs JP¥23.49 in 2Q 2022)

Japan Lifeline Co., Ltd. Provides Year End Dividend Guidance for the Year Ending March 31, 2023

Consensus forecasts updated

Japan Lifeline Co., Ltd. Launches Series of In-House Products for Biliary-Pancreatic Endoscopy

Japan Lifeline Co., Ltd. Announces Executive Changes, Effective October 1, 2022 Respectively

Japan Lifeline Co., Ltd. to Report Q3, 2023 Results on Feb 01, 2023

First quarter 2023 earnings released: EPS: JP¥24.73 (vs JP¥21.17 in 1Q 2022)

Japan Lifeline Co., Ltd. Provides Consolidated Earnings Guidance for Six Months Ending September 30, 2022 and Year Ending March 31, 2023

Japan Lifeline Co., Ltd. to Report Q2, 2023 Results on Nov 02, 2022

Price target decreased to JP¥1,120

Japan Lifeline Co., Ltd. Announces Dividend for Year Ended March 31, 2022, Effective Date Is June 29, 2022

Full year 2022 earnings: EPS in line with expectations, revenues disappoint

Japan Lifeline Co., Ltd., Annual General Meeting, Jun 28, 2022

Consensus EPS estimates fall by 12%

Japan Lifeline Co., Ltd. Appoints Shigeki Kitayama as Operating Officer

Upcoming dividend of JP¥38.00 per share

Third quarter 2022 earnings: EPS misses analyst expectations

Japan Lifeline Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2022

Price target decreased to JP¥1,500

Japan Lifeline Co., Ltd. Provides Earnings Guidance for the Six Months Ending September 30, 2021 and Full Year of Ending March 31, 2022

First quarter 2022 earnings released: EPS JP¥21.17 (vs JP¥10.53 in 1Q 2021)

Metcela Inc. and Japan Lifeline Co., Ltd. Announces Initiation of Phase I Clinical Trial of MTC001 in Patients with Chronic Ischemic Heart Failure

VP, GM of CRM Business Division & Director Osamu Watanabe has left the company

Japan Lifeline Receives Regulatory Approval for HeartLight X3

Japan Lifeline Co., Ltd. Receives Regulatory Approval for Abdominal Stent Graft Alto

Full year 2021 earnings released: EPS JP¥24.90 (vs JP¥96.55 in FY 2020)

Japan Lifeline Co., Ltd. Provides Year End Cash Dividend Guidance for the Year Ending March 31, 2022

Consensus forecasts updated

Upcoming dividend of JP¥49.00 per share

New 90-day low: JP¥1,365

Cardiofocus, Inc. Announces Expanded Partnership with Japan Lifeline Co., Ltd

Third quarter 2021 earnings released: JP¥31.57 loss per share (vs JP¥27.44 profit in 3Q 2020)